| Nov 13 |
Earnings Scheduled For November 13, 2024
|
| Nov 7 |
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
|
| Oct 30 |
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
|
| Oct 28 |
Exploring High Growth Tech Stocks In The US October 2024
|
| Sep 27 |
High Growth Tech Stocks in the United States to Watch
|
| Sep 25 |
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
|
| Aug 26 |
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 26 |
Alvotech: Steady Progress Offers A Good Chance Of Upside
|
| Aug 19 |
Alvotech Second Quarter 2024 Earnings: EPS: US$0.25 (vs US$0.83 in 2Q 2023)
|
| Aug 17 |
Alvotech's (NASDAQ:ALVO) biggest owners are private equity firms who got richer after stock soared 19% last week
|
